Presentation Unmet Clinical Needs for Tricuspid Valve Interventions Presenter: Steven Yakubov September 25, 2019 REGISTER for free or LOG IN to view this content Policy & Practice Presentation TCT 2019 Tricuspid Valve Up Next Presentation TCT 43: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 4 Years Clinical Results Presenter: Bernhard Witzenbichler September 25, 2019 More slides + Presentation The Financial Implications of a TAVR Program: A Primer on Healthcare Economics and Reimbursement Presenter: Hemal Gada September 25, 2019 Presentation Introduction Presenter: Bagrat Alekyan September 25, 2019 We Recommend
Presentation TCT 43: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 4 Years Clinical Results Presenter: Bernhard Witzenbichler September 25, 2019
Presentation The Financial Implications of a TAVR Program: A Primer on Healthcare Economics and Reimbursement Presenter: Hemal Gada September 25, 2019